MXD1 and B-cell non-Hodgkin lymphoma: A schematic representation of working model for NL101 is illustrated in Figure 6B. Through the significant inhibition of miR-21 expression, NL101 efficiently blocks the c-Myc/miR-21/Mxd1 positive feedback loop and inhibits the growth of B cell lymphoma.